Study title: Efficacy and safety of Symbioflor 2 in children with irritable bowel syndrome (non-interventional trial); Martens -Probiotic treatment of irritable bowel syndrome in children -Symbioflor2en 2010
| Type of medicine: Non-centrally authorised vaccines | |||||
| Therapeutic area: Digestive System Diseases [C06] | |||||
| Brands: Please see report, Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: Bacterial culture with MGE-score of at least 8 consisting of 1.5–4.5 x 107 cells capable and not capable of reproduction and cell debris of Escherichia coli (DSM 17252) | |||||
| ATC code: A07FA08 | |||||
| Document link: | |||||
| Document date: 2011-09-28 | |||||
| Study number: | |||||
| EudraCT number: | |||||
| Scope of study: CLINICAL | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | Y | - | |